DOI: 10.36347/gamj.2023.v04i01.006

Pages: 37-42

Introduction: The diabetic foot is a frequent and serious complication of diabetes. The aim of this study is to determine the therapeutic and evolutionary of the diabetic foot at the Internal Medicine Unit of the Fousseyni Daou Hospital in Kayes. Methods: Descriptive retrospective study carried out from January 1, 2019 to December 31, 2019 (12 months) at the Internal Medicine Unit of the Fousseyni Daou Hospital in Kayes. Were included in the study, all patients hospitalized during the study period for diabetic foot. Results: the prevalence of diabetic foot was 46.26%. The age group of 50 -59 was the most represented with 41.94%. The average age was 49 years with extremes of 30 years and 79 years. The female sex predominated with a sex ratio of 0.63. Type 2 diabetes was found in 96.77% of patients. The most common types of foot lesions were: necrosis 22.58%; abscess 19.35%; ulceration 16.13%.The wound was classified according to the classification of the University of Texas: Stage B Grade 2: 45.16% followed by Stage B Grade 3: 22.58% and Stage D Grade 3: 16.13%. All our patients had received 100% insulin therapy on admission. The combination Amoxicillin + Clavlanic acid + Metronidazole was the most used probabilistic antibiotic therapy 29.03%. The surgical treatment was: conservative: flattening 38.71%; necrosectomy 41.94%; toe disarticulation 12.90% and amputation 6.45%. The amputation site was 100% leg. The outcome of the hospitalization was marked by a favorable evolution 80.64%; the referral to Bamako for superinfection 16.13% and death 3.23%. Conclusion: Foot lesions are common in diabetic patients at Kayes Hospital. The fight against the diabetic foot requires a preventive approach based on the examination of the feet for the early detection of wounds or pre-injury abnormalities, and to identify patients at high risk of wounds. The challenge is to limit the delay in setting up the treatment and the aggravation of the wounds.